Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbzena Regulatory News (ABZA)

  • There is currently no data for ABZA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TR-1: Notification of major holdings

29 Aug 2017 14:59

RNS Number : 2120P
Abzena PLC
29 August 2017
 

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

ABZENA PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

HARGREAVE HALE LIMITED

City and country of registered office (if applicable)

BLACKPOOL, ENGLAND

4. Full name of shareholder(s) (if different from 3.)v

Name

DISCRETIONARY CLIENTS

City and country of registered office (if applicable)

As above

5. Date on which the threshold was crossed or reachedvi:

24 / 08 / 2017

6. Date on which issuer notified (DD/MM/YYYY):

29 / 08 / 2017

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

12.0337

12.0337

 

213,639,236

 

Position of previous notification (if

applicable)

11.9401

11.9401

 

 

 

 

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00BN65QN46

25,708,700

12.0337

 

SUBTOTAL 8. A

25,708,700

12.0337

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

20,925,000 of the resulting shares are held in a unit trust operated by Marlborough Fund Managers Ltd, for whom Hargreave Hale Ltd manages the portfolio of investments on a discretionary basis.

 

Place of completion

HARGREAVE HALE LTD, BLACKPOOL, ENGLAND

Date of completion

29 AUGUST 2017

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLBXGDILUDBGRC
Date   Source Headline
11th Apr 20173:06 pmRNSDirector/PDMR Shareholding
7th Apr 20171:36 pmRNSGrant of options
5th Apr 20173:45 pmRNSResult of bookbuild
5th Apr 20177:00 amRNSProposed Placing of £25m
6th Mar 20177:00 amRNS'Abzena inside' product enters Phase II trial
3rd Mar 20177:00 amRNSPartner Halozyme to present poster at AACR
1st Mar 20177:00 amRNSMRC grant awarded to collaboration group
21st Feb 20177:01 amRNSAntibody manufacturing development agreement
21st Feb 20177:00 amRNSTrading and business update
8th Feb 20178:43 amEQSEdison issues outlook on Abzena
6th Feb 201710:55 amRNSTotal Voting Rights
31st Jan 201712:53 pmRNSHardman Research: ThioBridge deal update
24th Jan 20177:00 amRNSIssue of Equity
20th Jan 20177:00 amRNSThioBridge license agreement
9th Jan 20179:37 amRNSBlocklisting update
22nd Dec 20167:00 amRNSLicence agreement
13th Dec 20167:15 amRNSHardman Research: Opening new doors
30th Nov 20167:00 amRNSHalf year results
23rd Nov 20168:09 amRNS'Abzena inside' product study data to be presented
15th Nov 201612:42 pmRNSNotice of half year results
2nd Nov 20167:00 amRNSLicensed product candidate update
24th Oct 20167:00 amRNSSenior Executive Appointments
21st Oct 20167:00 amRNSLicensed product candidate update
22nd Sep 20169:30 amRNSLicensed product candidate update
19th Sep 20162:28 pmRNSChange of Nominated Adviser and Broker
14th Sep 20163:58 pmRNSEdison issues research update on Abzena (ABZA)
13th Sep 20163:41 pmRNSResult of AGM
13th Sep 20167:00 amRNSDirectorate Change
13th Sep 20167:00 amRNSAGM Business Update
16th Aug 201612:20 pmRNSDirector/PDMR Shareholding and Exercise of Options
9th Aug 20162:30 pmRNSNotice of AGM
28th Jul 201611:45 amRNSEdison issues research update on Abzena (ABZA)
25th Jul 20167:00 amRNSManufacturing agreement
14th Jul 201610:37 amRNSJoint venture with Baylor Research Institute
6th Jul 20163:58 pmRNSBlock Listing Update
27th Jun 20164:46 pmRNSDirector Dealings
24th Jun 20169:45 amRNSExercise of warrants
22nd Jun 201610:12 amRNSEdison issues research review on Abzena (ABZA)
15th Jun 20164:09 pmRNSAnnual Report and Accounts
14th Jun 20167:00 amRNSFull year results
26th May 20167:00 amRNSNotice of Results
5th Apr 20169:20 amRNSExercise of Employee Share Options
1st Apr 20169:48 amRNSExercise of Share Options and Director Dealings
16th Mar 20169:45 amRNSExercise of Employee Share Options
9th Mar 201612:47 pmRNSExercise of Employee Share Options
9th Mar 20167:00 amRNSBusiness update
8th Feb 20163:14 pmRNSExercise of employee share options
4th Feb 20162:33 pmRNSHolding(s) in Company
25th Jan 20167:00 amRNSSignificant licence deal for ThioBridgeT
18th Jan 20167:00 amRNSAntitope collaboration awarded European grant

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.